Opinion: The Burden of Proof

Universities that profit from football programs need to honestly assess their responsibilities when it comes to head injury research.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SXC.HU, SUPERCOLORLast August the National Football League (NFL) agreed to pay players $765 million to settle a lawsuit involving head trauma and neurodegenerative disease. While our understanding of head injury impacts on high school and college footballers remains incomplete, there is enough evidence to compel universities to assess their responsibilities and organize their diverse capabilities to address the problem.

Key to such an assessment is recognizing that the burden of proof varies for purposes of science and purposes of policy, and that both levels of proof are subject to significant ambiguity. Failure to grapple with these ambiguities could leave some universities sounding much like other organizations and private companies that have stubbornly denied responsibility for dangerous products.

A common deception used to refute mounting scientific evidence is to argue that the burden of proof for policy change must rise to scientific standards. However, proof for purposes of science is an elusive concept, since nearly every scientific explanation raises further questions. Throughout the 1960s, ‘70s, and ‘80s, the tobacco industry consistently refuted strong correlative evidence about smoking and lung cancer by citing gaps in mechanistic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • David Rubenson

    This person does not yet have a bio.
  • Paul Salvaterra

    This person does not yet have a bio.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb